|
⚲
|
| Keyboard |
| Ian Clements | |
|---|---|
| Firm | |
| Address | c/o Mirum Pharmaceuticals, Inc 950 Tower Lane, Suite 1050 Foster City, CA 94404 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | 021-384864 | Executive Officer | 10.0 M of 10.0 M |
||
| Stembiosys Inc | 021-384752 | Director | of 1.5 M |
||
| Stembiosys Inc | 021-357604 | Director | of 0.5 M |
||
| Stembiosys Inc | 021-342326 | Director | 1.4 M of 3.0 M |
||
| Cytobioscience Inc | 021-307871 | Director | 1.5 M of 1.5 M |
||
| Stembiosys Inc | 021-261701 | Director | 4.1 M of 4.3 M |
||
| Cytobioscience Inc | 021-236674 | Director | 15.8 M of 21.8 M |
||
| Viroxis Corp | 021-174538 | Executive Officer | 1.0 M of 10.0 M |
||
| Viroxis Corp | 021-149227 | Executive Officer | 1.2 M of 2.5 M |
||
| Viroxis Corp | 021-142612 | Executive Officer | 7.8 M of 7.8 M |
||
| Viroxis Corp | 021-137813 | Executive Officer | 0.5 M of 0.5 M |
||
| Targeted Venture Management LLC | |||||
| Targeted Technology Fund II LP | 021-206001 | Director | 37.2 M of 50.0 M |
14.1 M | |